↓ Skip to main content

Sulthiame monotherapy for epilepsy

Overview of attention for article published in Cochrane database of systematic reviews, March 2014
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (60th percentile)

Mentioned by

twitter
4 tweeters

Citations

dimensions_citation
11 Dimensions

Readers on

mendeley
76 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Sulthiame monotherapy for epilepsy
Published in
Cochrane database of systematic reviews, March 2014
DOI 10.1002/14651858.cd010062.pub2
Pubmed ID
Authors

Philip Milburn-McNulty, Graham Powell, Graeme J Sills, Anthony G Marson

Abstract

Epilepsy is a common neurological condition characterised by recurrent seizures. Sulthiame (STM) is widely used as an antiepileptic drug in Europe and Israel. In this review, we present a summary of evidence for the use of STM as monotherapy in epilepsy.

Twitter Demographics

The data shown below were collected from the profiles of 4 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 76 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 1%
Ethiopia 1 1%
South Africa 1 1%
Unknown 73 96%

Demographic breakdown

Readers by professional status Count As %
Student > Master 14 18%
Student > Bachelor 11 14%
Researcher 10 13%
Student > Ph. D. Student 8 11%
Student > Doctoral Student 6 8%
Other 13 17%
Unknown 14 18%
Readers by discipline Count As %
Medicine and Dentistry 35 46%
Nursing and Health Professions 10 13%
Biochemistry, Genetics and Molecular Biology 3 4%
Social Sciences 3 4%
Computer Science 2 3%
Other 6 8%
Unknown 17 22%

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 04 September 2014.
All research outputs
#6,743,760
of 12,527,219 outputs
Outputs from Cochrane database of systematic reviews
#7,227
of 8,923 outputs
Outputs of similar age
#73,949
of 189,507 outputs
Outputs of similar age from Cochrane database of systematic reviews
#156
of 201 outputs
Altmetric has tracked 12,527,219 research outputs across all sources so far. This one is in the 45th percentile – i.e., 45% of other outputs scored the same or lower than it.
So far Altmetric has tracked 8,923 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 21.2. This one is in the 25th percentile – i.e., 25% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 189,507 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 60% of its contemporaries.
We're also able to compare this research output to 201 others from the same source and published within six weeks on either side of this one. This one is in the 21st percentile – i.e., 21% of its contemporaries scored the same or lower than it.